The report “Lab Automation Market by
Equipment and Software (Robotic Arms, Microplate Readers, LIMS),
Applications (Drug Discovery, Clinical Diagnostics, Genomics), End Users
(Biotechnology and Pharmaceuticals, Diagnostic Labs) – Global Forecast
to 2022″, The lab automation market is expected to reach USD
5.20 Billion by 2022 from an estimated USD 4.06 Billion in 2017, at a
CAGR of 5.1%. Factors such as process miniaturization, high demand for
lab automation equipment in drug discovery and clinical diagnostics,
higher reproducibility and accuracy, and large workforce demand and
supply gap are likely to drive the growth of this market.
Early buyers will receive 10% customization on reports.
Browse 279 Market Data Tables and 31 Figures spread through 235 Pages and in-depth TOC on “Lab
Automation Market by Equipment and Software (Robotic Arms, Microplate
Readers, LIMS), Applications (Drug Discovery, Clinical Diagnostics,
Genomics), End Users (Biotechnology and Pharmaceuticals, Diagnostic
Labs) – Global Forecast to 2022”
https://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html
https://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html
Early buyers will receive 10% customization on reports.
The automated workstations segment to account for the largest market share in 2017
Based on equipment and software, the market is
segmented into automated workstations, off-the-shelf workcells, robotic
systems, automated storage and retrieval system, software, and other
equipment. In 2017, the automated workstations segment is expected to
account for the largest share of the lab automation market. The high
demand for automation in liquid handling is the key factor driving
market growth in this segment. Automated workstations offer advantages
such as enhanced accuracy, and reduced time and cost.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=1158
The genomics solutions segment to grow at the highest CAGR
Based on applications, the lab automation market is
segmented into drug discovery, clinical diagnostics, genomics solutions,
proteomics solutions, microbiology, and other applications. The
genomics solutions segment is expected to grow at the highest CAGR
during the forecast period. The use of automation is on the rise in
genomics for high-throughput requirements, providing greater
reproducibility and throughput as compared to manual methods.
North America to command the largest share of the lab automation market in 2017
North America is expected to command the largest
share of the global lab automation market in 2017. The increasing
adoption of lab automation systems, implementation of the Affordable
Care Act (ACA) in 2010 and economy stimulus programs such as increased
funds for the National Institutes of Health (NIH) and the National
Science Foundation (NSF), and increased R&D activities by
biotechnology and pharmaceutical companies are driving growth in the lab
automation market in North America.
The major players in the lab automation market
include Tecan Group (Switzerland), PerkinElmer (US), Danaher (Beckman
Coulter & Molecular Devices) (US), Thermo Fisher (US), Agilent
Technologies (US), Hamilton Robotics (US), Abbot Diagnostics (US),
Eppendorf (Germany), QIAGEN (Netherlands), Roche Diagnostics
(Switzerland), and Siemens Healthcare (Germany).
Get Sample Copy: https://www.marketsandmarkets.com/requestsample.asp?id=1158
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research
on 30,000 high growth niche opportunities/threats which will impact 70%
to 80% of worldwide companies’ revenues. Currently servicing 5000
customers worldwide including 80% of global Fortune 1000 companies as
clients. Almost 75,000 top officers across eight industries worldwide
approach MarketsandMarkets™ for their painpoints around revenues
decisions.
Our 850 fulltime analyst and SMEs at
MarketsandMarkets™ are tracking global high growth markets following the
“Growth Engagement Model – GEM”. The GEM aims at proactive
collaboration with the clients to identify new opportunities, identify
most important customers, write “Attack, avoid and defend” strategies,
identify sources of incremental revenues for both the company and its
competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies
this year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research
ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence
and market research platform, “RT” connects over 200,000 markets and
entire value chains for deeper understanding of the unmet insights along
with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Article Credit: Healthcare DC
Comments
Post a Comment